• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对特定从业者的颈项透明层中位数,以提高早孕期筛查效能。

Practitioner-specific medians for nuchal translucency to improve first-trimester screening performance.

机构信息

California Department of Public Health, Richmond, CA, USA.

出版信息

Obstet Gynecol. 2012 Apr;119(4):785-94. doi: 10.1097/AOG.0b013e31824be8f5.

DOI:10.1097/AOG.0b013e31824be8f5
PMID:22433342
Abstract

OBJECTIVE

Nuchal translucency medians are used to convert nuchal translucency measurements to multiple of the median values for use in risk assessment. There has been much debate about the use of practitioner-specific medians instead of population-based medians to correct for practitioner bias. This study examined data from the California Prenatal Screening Program to evaluate the effect of individual medians on screening performance.

METHODS

For this retrospective study, we identified first-trimester specimens in the California Prenatal Screening Program database for which screening results were calculated using a practitioner-specific median (n=55,286) and recalculated risk assessment using a population-based median. We looked at positive rates for Down syndrome and Trisomy 18 as well as overall screening results. We also looked at the recalculated risks for cases in which there has been a positive diagnosis of a chromosomal abnormality to determine if cases would have been missed if practitioner-specific medians had not been used.

RESULTS

Nuchal translucency multiples of the median would be lower for the majority of nuchal translucency practitioners if a population-based median were used instead of practitioner-specific medians. Outcomes data from the California Prenatal Screening Program's database indicate that 14 positively diagnosed cases would have been missed by the screening program if population-based medians had been used.

CONCLUSION

The use of practitioner-specific medians corrects for practitioner bias in measuring nuchal translucency. Practitioner-specific medians improve screening performance and help meet detection rate goals.

LEVEL OF EVIDENCE

II.

摘要

目的

颈项透明层中位数用于将颈项透明层测量值转换为中位数的倍数,以便用于风险评估。关于使用特定于从业者的中位数而不是基于人群的中位数来纠正从业者偏差,已经有很多争论。本研究通过加州产前筛查计划的数据来评估个体中位数对筛查性能的影响。

方法

在这项回顾性研究中,我们从加州产前筛查计划数据库中确定了在第一孕期进行的标本,这些标本的筛查结果是使用特定于从业者的中位数计算的(n=55286),并使用基于人群的中位数重新计算风险评估。我们观察了唐氏综合征和 18 三体的阳性率以及整体筛查结果。我们还观察了在有染色体异常阳性诊断的情况下重新计算的风险,以确定如果不使用特定于从业者的中位数,是否会错过病例。

结果

如果使用基于人群的中位数而不是特定于从业者的中位数,大多数颈项透明层从业者的颈项透明层中位数倍数将会降低。来自加州产前筛查计划数据库的结果数据表明,如果使用基于人群的中位数,该筛查计划将错过 14 例阳性诊断病例。

结论

使用特定于从业者的中位数可以纠正测量颈项透明层时的从业者偏差。特定于从业者的中位数可提高筛查性能并有助于达到检测率目标。

证据水平

II。

相似文献

1
Practitioner-specific medians for nuchal translucency to improve first-trimester screening performance.针对特定从业者的颈项透明层中位数,以提高早孕期筛查效能。
Obstet Gynecol. 2012 Apr;119(4):785-94. doi: 10.1097/AOG.0b013e31824be8f5.
2
Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.撒丁岛12495例妊娠中的胎儿颈部透明带筛查。
Ultrasound Obstet Gynecol. 2001 Dec;18(6):649-51. doi: 10.1046/j.0960-7692.2001.00583.x.
3
Maternal weight and ethnic adjustment within a first-trimester Down syndrome and trisomy 18 screening program.孕早期唐氏综合征和18三体综合征筛查项目中的孕妇体重及种族校正
Prenat Diagn. 2005 Aug;25(8):635-40. doi: 10.1002/pd.1188.
4
[Evaluation of a programme for the prenatal screening for Down's syndrome by ultrasonographic nuchal translucency measurement and serum determinations in the first trimester of pregnancy].[通过超声测量孕早期胎儿颈部透明带厚度及血清学检测进行唐氏综合征产前筛查项目的评估]
Ned Tijdschr Geneeskd. 2005 Dec 10;149(50):2795-9.
5
Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.在一站式诊所中使用孕早期超声和母体血清生化指标对双胎妊娠进行21三体综合征筛查:三年经验回顾
BJOG. 2003 Mar;110(3):276-80.
6
Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.在高危人群中通过测量胎儿颈部透明带来筛查唐氏综合征。
Ultrasound Obstet Gynecol. 1998 Sep;12(3):156-62. doi: 10.1046/j.1469-0705.1998.12030156.x.
7
First-trimester ultrasonographic screening for trisomy 21 using fetal nuchal translucency and nasal bone.孕早期使用胎儿颈部透明带和鼻骨对21三体综合征进行超声筛查。
Obstet Gynecol. 2007 May;109(5):1040-5. doi: 10.1097/01.AOG.0000259311.87056.5e.
8
Nuchal translucency and nasal bone for trisomy 21 screening: single center experience.用于21三体综合征筛查的颈部透明带厚度和鼻骨:单中心经验
Croat Med J. 2005 Oct;46(5):786-91.
9
Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome.孕早期颈部透明带厚度对孕中期唐氏综合征母体血清生化筛查的影响。
Ultrasound Obstet Gynecol. 1997 Oct;10(4):261-4. doi: 10.1046/j.1469-0705.1997.10040261.x.
10
Relation between increased fetal nuchal translucency thickness and chromosomal defects.胎儿颈部半透明厚度增加与染色体缺陷之间的关系。
Obstet Gynecol. 2006 Jan;107(1):6-10. doi: 10.1097/01.AOG.0000191301.63871.c6.

引用本文的文献

1
Twin chorionicity and zygosity both vary with maternal age.双胞胎的绒毛膜性和同卵性都随母亲年龄而变化。
Prenat Diagn. 2021 Aug;41(9):1074-1079. doi: 10.1002/pd.5997. Epub 2021 Jun 27.
2
The utility of nuchal translucency ultrasound in identifying rare chromosomal abnormalities not detectable by cell-free DNA screening.颈项透明层超声在识别细胞游离 DNA 筛查无法检测的罕见染色体异常中的应用。
Prenat Diagn. 2020 Jan;40(2):185-190. doi: 10.1002/pd.5583. Epub 2019 Dec 2.
3
Association of early-preterm birth with abnormal levels of routinely collected first- and second-trimester biomarkers.
与早孕期早产相关的常规收集的第一和第二孕期生物标志物的异常水平。
Am J Obstet Gynecol. 2013 Jun;208(6):492.e1-11. doi: 10.1016/j.ajog.2013.02.012. Epub 2013 Feb 24.